Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Bradykinin B1 receptor (B1R) is a G protein-coupled receptor that is typically absent under normal physiological conditions but is highly inducible following tissue injury or in inflammatory states. Its activation by kinins like desArg^9-bradykinin mediates inflammatory responses, pain, and cardiovascular effects. It is a target for potential treatment strategies for inflammatory disorders and cardiovascular diseases.
Agonists bind to B1 receptor leading to increased cytosolic calcium ion concentration, initiating inflammatory responses. Antagonists block this binding and reduce inflammation and pain.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bradykinin B1 receptor (None).